Loading stock data…
$1.29-0.11 (-7.86%)
Cibus, Inc.
Cibus, Inc. in the Healthcare sector is trading at $1.29 with a market capitalization of $120M. Wall Street consensus targets $14.33 (3 analysts), implying a +1011.1% move over the next 12 months. The stock is currently near its 52-week low of $1.09, remaining 31.4% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $994,000↓ | $1.68M↑ | $1.06M↑ | $615,000↓ | $933,000 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$12.93M↓ | -$12.12M↑ | -$13.46M↑ | -$15.44M↑ | -$17.95M |
| Net Income | -$22.14M↓ | -$21.22M↑ | -$31.29M↓ | -$23.54M↑ | -$25.37M |
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers...